h9 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
95
Structured Review
ATCC
h9
H9, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 331 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h9/H9/custom%40htb-176%4042473281
Average 95 stars, based on 331 article reviews
H9, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 331 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h9/H9/custom%40htb-176%4042473281
Average 95 stars, based on 331 article reviews
h9 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Binding Assay:Article Title: Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity Article Snippet: rovided in the supplemental Methods . NK cell cytotoxic potential was evaluated by CD107a expression after 5-hour coculture with 4 hematological malignancy cell lines: H9 (T-cell non-Hodgkin lymphoma, Suspension:Article Title: Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity Article Snippet: rovided in the supplemental Methods . NK cell cytotoxic potential was evaluated by CD107a expression after 5-hour coculture with 4 hematological malignancy cell lines: H9 (T-cell non-Hodgkin lymphoma, Cell Culture:Article Title: Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity Article Snippet: rovided in the supplemental Methods . NK cell cytotoxic potential was evaluated by CD107a expression after 5-hour coculture with 4 hematological malignancy cell lines: H9 (T-cell non-Hodgkin lymphoma, Expressing:Article Title: Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity Article Snippet: rovided in the supplemental Methods . NK cell cytotoxic potential was evaluated by CD107a expression after 5-hour coculture with 4 hematological malignancy cell lines: H9 (T-cell non-Hodgkin lymphoma, Control:Article Title: Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity Article Snippet: rovided in the supplemental Methods . NK cell cytotoxic potential was evaluated by CD107a expression after 5-hour coculture with 4 hematological malignancy cell lines: H9 (T-cell non-Hodgkin lymphoma, Derivative Assay:Article Title: Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity Article Snippet: rovided in the supplemental Methods . NK cell cytotoxic potential was evaluated by CD107a expression after 5-hour coculture with 4 hematological malignancy cell lines: H9 (T-cell non-Hodgkin lymphoma, Isolation:Article Title: Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity Article Snippet: rovided in the supplemental Methods . NK cell cytotoxic potential was evaluated by CD107a expression after 5-hour coculture with 4 hematological malignancy cell lines: H9 (T-cell non-Hodgkin lymphoma, |